| Dr Denise A Mulvaney, MD | |
|
1020 Baltimore Pike, Suite 100, Glen Mills, PA 19342-1365 | |
| (484) 227-7790 | |
| (484) 227-7791 |
| Full Name | Dr Denise A Mulvaney |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 1020 Baltimore Pike, Glen Mills, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437219086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD044759L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riddle Memorial Hospital | Media, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.
BioLineRx, a biopharmaceutical development company, today announced that data from the successfully completed Phase IIb EAGLE study of BL-1020, a first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, will be presented at the 3rd European Conference on Schizophrenia Research (ECSR) held in Berlin, Germany.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.
The Military Order of the Purple Heart Service Foundation and the UW Medicine Division of Pain Medicine are joining forces to assist veterans with treatment for Post-Traumatic Stress, Traumatic Brain Injury, and acute and chronic pain.
› Verified 4 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.
BioLineRx, a biopharmaceutical development company, today announced that data from the successfully completed Phase IIb EAGLE study of BL-1020, a first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, will be presented at the 3rd European Conference on Schizophrenia Research (ECSR) held in Berlin, Germany.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.
The Military Order of the Purple Heart Service Foundation and the UW Medicine Division of Pain Medicine are joining forces to assist veterans with treatment for Post-Traumatic Stress, Traumatic Brain Injury, and acute and chronic pain.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Denise A Mulvaney, MD 1020 Baltimore Pike, Suite 100, Glen Mills, PA 19342-1365 Ph: (484) 227-7790 | Dr Denise A Mulvaney, MD 1020 Baltimore Pike, Suite 100, Glen Mills, PA 19342-1365 Ph: (484) 227-7790 |
News Archive
CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.
BioLineRx, a biopharmaceutical development company, today announced that data from the successfully completed Phase IIb EAGLE study of BL-1020, a first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, will be presented at the 3rd European Conference on Schizophrenia Research (ECSR) held in Berlin, Germany.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.
The Military Order of the Purple Heart Service Foundation and the UW Medicine Division of Pain Medicine are joining forces to assist veterans with treatment for Post-Traumatic Stress, Traumatic Brain Injury, and acute and chronic pain.
› Verified 4 days ago
Nicholas A Giuliani, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 Baltimore Pike, Suite 100, Glen Mills, PA 19342 Phone: 484-227-7790 Fax: 484-227-7791 | |
John Richard Luksch, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Evergreen Dr Ste 201, Glen Mills, PA 19342 Phone: 267-339-3558 Fax: 267-339-3763 | |
Dr. Michael Benjamin Kuczmarski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Maris Grove Way, Glen Mills, PA 19342 Phone: 610-387-4520 Fax: 610-387-4526 | |
Dr. Christie O Mousaw, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Evergreen Dr, Suite 310, Glen Mills, PA 19342 Phone: 610-579-3564 Fax: 610-579-3566 | |
Dr. Robert P. Denitzio, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1020 Baltimore Pike Ste 100, Glen Mills, PA 19342 Phone: 484-227-7858 | |
Dr. Michael A Krafchick, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Evergreen Dr, Suite 1500, Glen Mills, PA 19342 Phone: 610-579-3444 Fax: 610-579-3449 | |
Dr. Joshua B Feinberg, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Evergreen Dr, Glen Mills, PA 19342 Phone: 610-579-3480 Fax: 610-579-3485 |